CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
CAR-T(uning) aims to enhance chimeric antigen receptor T-cell therapy for cancer treatment by addressing challenges like therapy persistence and tumor-induced immunosuppression. The project focuses on non-small cell lung cancer, utilizing a novel mechanism to improve immune response and potentially broaden the applicab…
CAR-T(uning) will assess the technical and commercial feasibility of an improved and broadly applicable chimeric antigen receptor T-cell (CAR-T) approach based on a novel implemented mechanism of action.
There is an urgent need for more effective treatment strategies against cancer, which remains the leading cause of death worldwide.
Immuno-oncology regimens such as, immune checkpoint blockade therapy (ICT) and CAR-T therapy emerged as powerful tools in cancer treatment, however, in the majority…
MEDIZINISCHE UNIVERSITAT INNSBRUCK
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
